Community
We Welcome Your Interest
The CBI community includes stakeholders from across the healthcare innovation system. CBI provides its community members with the opportunity to help shape the future of biomedical innovation. We welcome your interest in collaborating with us as we shape our ongoing strategic vision and inter-disciplinary research and educational activities.
In addition to the broad engagement of the MIT and Harvard-MIT Division of Health Science and Technology (HST) research communities, CBI greatly appreciates the support and participation of the following organizations:
Consortium Members and Collaborators (*Consortium Members)
| Aetna | Health Canada | Millipore* |
| Alnylam* | Health Sci. Authority of Singapore (HSA) | National Institutes of Health (NIH) |
| Amgen* | Inno Biologics Sdn. Bhd.* | Natl. Inst. of Standards & Technology (NIST) |
| Biogen Idec* | Johnson & Johnson* | NICE |
| Bristol-Myers Squibb* | KEW Group | Novartis* |
| Brookings Institution | Life Technologies* | Pfizer* |
| Cntrs. for Disease Cont. and Prev. (CDC) | Massachusetts General Hospital | Quintiles* |
| Dana Farber Cancer Institute | Memorial Sloan-Kettering | sanofi-aventis |
| Eur. Medicines Agency (EMA) | Merrimack Pharmaceuticals* | sanofi pasteur* |
| Genentech* | Metabolix* | University of Prince Edward Island |
| Georgetown University | Millennium Pharmaceuticals* | US Food & Drug Association (FDA) |
CBI is also grateful to the following foundations for their financial support:
| Alfred P. Sloan Foundation |
| Kauffman Foundation |
| Massachusetts Technology Collaborative (John Adams Innovation Institute grant) |
| Merck Company Foundation (Program on Pharmaceutical Policy Issues grant) |
For general information on supporting CBI’s goals and mission, please contact us at cbi@mit.edu.
For additional information on supporting the NEWDIGS program, please contact Gigi Hirsch at ghirsch@mit.edu.
For additional information on supporting the BioMAN program, please contact Stacy Springs at ssprings@mit.edu.